Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines

The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 22; no. 7; pp. 2113 - 2122
Main Authors Temburnikar, Kartik W., Zimmermann, Sarah C., Kim, Nathaniel T., Ross, Christina R., Gelbmann, Christopher, Salomon, Christine E., Wilson, Gerald M., Balzarini, Jan, Seley-Radtke, Katherine L.
Format Journal Article
LanguageEnglish
Published OXFORD Elsevier Ltd 01.04.2014
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein.
AbstractList The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein.
The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein. (C) 2014 Elsevier Ltd. All rights reserved.
The in vitro evaluation of thieno[3,2- d ]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer cell lines. A structure activity relationship study indicated the necessity of the chlorine at the C4-position for biological activity. The two most active compounds 1 and 2 were found to induce apoptosis in the leukemia L1210 cell line. Additionally, the compounds were screened against a variety of other microbial targets and as a result, selective activity against several fungi was also observed. The synthesis and preliminary biological results are reported herein.
Author Gelbmann, Christopher
Wilson, Gerald M.
Temburnikar, Kartik W.
Seley-Radtke, Katherine L.
Salomon, Christine E.
Zimmermann, Sarah C.
Ross, Christina R.
Kim, Nathaniel T.
Balzarini, Jan
AuthorAffiliation d Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA
a Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
b Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA
c Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
AuthorAffiliation_xml – name: b Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA
– name: d Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA
– name: c Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
– name: a Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
Author_xml – sequence: 1
  givenname: Kartik W.
  surname: Temburnikar
  fullname: Temburnikar, Kartik W.
  organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
– sequence: 2
  givenname: Sarah C.
  surname: Zimmermann
  fullname: Zimmermann, Sarah C.
  organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
– sequence: 3
  givenname: Nathaniel T.
  surname: Kim
  fullname: Kim, Nathaniel T.
  organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
– sequence: 4
  givenname: Christina R.
  surname: Ross
  fullname: Ross, Christina R.
  organization: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA
– sequence: 5
  givenname: Christopher
  surname: Gelbmann
  fullname: Gelbmann, Christopher
  organization: Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA
– sequence: 6
  givenname: Christine E.
  surname: Salomon
  fullname: Salomon, Christine E.
  organization: Center for Drug Design, University of Minnesota, 516 Delaware St. SE, Minneapolis, MN 55455, USA
– sequence: 7
  givenname: Gerald M.
  surname: Wilson
  fullname: Wilson, Gerald M.
  organization: Department of Biochemistry and Molecular Biology, University of Maryland School of Medicine, 108 N. Greene Street, Baltimore, MD 21201, USA
– sequence: 8
  givenname: Jan
  surname: Balzarini
  fullname: Balzarini, Jan
  organization: Rega Institute for Medical Research, KU Leuven, Minderbroedersstraat 10, B-3000 Leuven, Belgium
– sequence: 9
  givenname: Katherine L.
  surname: Seley-Radtke
  fullname: Seley-Radtke, Katherine L.
  email: kseley@umbc.edu
  organization: Department of Chemistry and Biochemistry, University of Maryland Baltimore County, 1000 Hilltop Circle, Baltimore, MD 21250, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24631358$$D View this record in MEDLINE/PubMed
BookMark eNqNkUtrGzEUhUVJaJy0P6Cb4mWhmYleoxlRKASnj0Agm3ZVitBIV7HMWHIl2SX_vgp2TbspXV2BvnN0dc45OgkxAEKvCG4JJuJq1Y5r01JMeItpixl7hmaEC94wJskJmmEphgYPUpyh85xXGGPKJXmOzigXjLBumKGb61D8JsXJO0i6-B3MtanDFw95Ht18qaf4AEEXsPOy9BDiN3ZJG_t985j82lsfIL9Ap05PGV4e5gX6-vHDl8Xn5u7-0-3i-q4xfOCl0cBA4H6QlMpRdoJLznvmRkp7ojsuhMDOdEZYg3U_OAejZZ0jVhMJrHeSXaD3e9_NdlyDNRBK0pPa1EV0elRRe_X3TfBL9RB3inei47KvBm8OBin-2EIuau2zgWnSAeI2K9JRzCRmlFeU7FGTYs4J3PEZgtVT-mqlavrqKX2FqarpV83rP_c7Kn7HXYG3e-AnjNFlU-M0cMRqP4xxxvqhngip9PD_9MKXWl8Mi7gNpUrf7aVQ69h5SOogtz6BKcpG_49__ALwsbjb
CitedBy_id crossref_primary_10_1002_cmdc_201700641
crossref_primary_10_2174_0113852728266665231101112129
crossref_primary_10_1002_slct_202400563
crossref_primary_10_1021_acs_jmedchem_0c01100
crossref_primary_10_1134_S1070428020110147
crossref_primary_10_1016_j_bmcl_2015_02_071
crossref_primary_10_1080_15421406_2019_1706268
crossref_primary_10_1002_slct_202400514
crossref_primary_10_1590_0001_3765201820170798
crossref_primary_10_1515_hc_2015_0160
crossref_primary_10_1002_chem_201501334
crossref_primary_10_1016_j_tiv_2019_05_009
crossref_primary_10_1055_s_0042_1751508
crossref_primary_10_1016_j_heliyon_2018_e00661
crossref_primary_10_1016_j_ejmech_2019_112024
crossref_primary_10_3390_molecules22050788
crossref_primary_10_3390_molecules24142656
crossref_primary_10_1134_S1070428016040187
crossref_primary_10_1039_C7RA04261B
crossref_primary_10_1016_j_molstruc_2023_137022
crossref_primary_10_1515_acph_2017_0028
crossref_primary_10_3390_ph15010035
crossref_primary_10_1016_j_ijms_2020_116411
crossref_primary_10_1016_j_bmc_2015_06_025
Cites_doi 10.1021/jo0155613
10.1016/j.cell.2011.02.013
10.1021/jm0601809
10.1021/ol101482h
10.1021/jm2009327
10.1158/1535-7163.MCT-11-0446
10.1038/cdd.2008.131
10.1016/j.canlet.2010.12.012
10.1021/jm901284w
10.1021/ja9064359
10.1186/1476-4598-10-35
10.1016/j.bmc.2004.12.011
10.1016/j.tet.2007.01.075
10.1021/jo400913k
10.1080/15257770.2012.656212
10.1038/nrc1587
10.1081/NCN-200027660
10.1021/jm3003747
10.1016/j.bmc.2006.06.046
10.1016/j.bmcl.2003.10.030
10.1021/ml200198x
10.1021/jm000326i
10.2144/000113089
10.1021/ml100230n
10.1021/jm300016v
10.1016/j.canlet.2010.09.012
10.1021/jm800295d
10.1084/jem.97.5.695
10.1002/jhet.5570240354
10.1046/j.1359-4117.2002.01002.x
10.1021/jo00154a005
10.1016/S0040-4039(00)78826-5
10.1002/jhet.5570230631
10.1016/0040-4039(81)80031-7
10.1021/jm9903949
10.2174/1874467210801030244
10.1016/0022-1759(95)00072-I
10.1021/jm00117a019
10.1080/15257779408011862
10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J
10.1021/jo00155a026
10.1021/jm981012m
10.1021/jo00145a005
10.1021/jm00014a027
10.1055/s-1974-23448
10.1016/j.tet.2008.09.011
10.1093/nass/nrn321
10.1080/15257779408011866
ContentType Journal Article
Copyright 2014 Elsevier Ltd
Copyright © 2014 Elsevier Ltd. All rights reserved.
Copyright_xml – notice: 2014 Elsevier Ltd
– notice: Copyright © 2014 Elsevier Ltd. All rights reserved.
DBID 1KM
BLEPL
DTL
GNMZZ
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7QO
8FD
FR3
P64
5PM
DOI 10.1016/j.bmc.2014.02.033
DatabaseName Index Chemicus
Web of Science Core Collection
Science Citation Index Expanded
Web of Science - Science Citation Index Expanded - 2014
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
Biotechnology Research Abstracts
Technology Research Database
Engineering Research Database
Biotechnology and BioEngineering Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle Web of Science
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Engineering Research Database
Biotechnology Research Abstracts
Technology Research Database
Biotechnology and BioEngineering Abstracts
DatabaseTitleList Engineering Research Database

MEDLINE
Web of Science

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 1KM
  name: Index Chemicus
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/woscc/search-with-editions?editions=WOS.IC
  sourceTypes:
    Enrichment Source
    Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Anatomy & Physiology
Chemistry
EISSN 1464-3391
EndPage 2122
ExternalDocumentID 10_1016_j_bmc_2014_02_033
24631358
000334337800011
S0968089614001394
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: National Institutes of Health; United States Department of Health & Human Services; National Institutes of Health (NIH) - USA
  grantid: R01GM073645
– fundername: NCI NIH HHS
  grantid: R01 CA102428
– fundername: NIGMS NIH HHS
  grantid: R01GM073645 KSR
– fundername: NIGMS NIH HHS
  grantid: R01 GM073645
– fundername: NIGMS NIH HHS
  grantid: T32 GM066706
GroupedDBID ---
--K
--M
.~1
0R~
1B1
1RT
1~.
1~5
23N
4.4
457
4G.
5GY
5VS
7-5
71M
8P~
9JM
9JN
AABNK
AACTN
AAEDT
AAEDW
AAIAV
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AARLI
AATCM
AAXUO
ABBQC
ABFNM
ABGSF
ABJNI
ABLVK
ABMAC
ABMZM
ABUDA
ABXDB
ABYKQ
ABZDS
ACDAQ
ACGFS
ACIUM
ACRLP
ADBBV
ADECG
ADEZE
ADUVX
AEBSH
AEHWI
AEKER
AENEX
AFKWA
AFTJW
AFXIZ
AFZHZ
AGUBO
AGYEJ
AHHHB
AIEXJ
AIKHN
AITUG
AJBFU
AJOXV
AJRQY
AJSZI
ALCLG
ALMA_UNASSIGNED_HOLDINGS
AMFUW
AMRAJ
ANZVX
AXJTR
BKOJK
BLXMC
BNPGV
CS3
DOVZS
DU5
EBS
EFJIC
EFLBG
EJD
EO8
EO9
EP2
EP3
F5P
FDB
FIRID
FLBIZ
FNPLU
FYGXN
G-Q
GBLVA
IHE
J1W
KOM
LCYCR
LZ2
M29
M2Z
M34
M41
MO0
N9A
O-L
O9-
OAUVE
OGGZJ
OZT
P-8
P-9
P2P
PC.
Q38
RIG
ROL
RPZ
SCC
SDF
SDG
SDP
SES
SPC
SPCBC
SSH
SSK
SSP
SSU
SSZ
T5K
UPT
XPP
YK3
~02
~G-
1KM
AAXKI
AKRWK
BLEPL
DTL
GROUPED_WOS_SCIENCE_CITATION_INDEX_EXPANDED
CGR
CUY
CVF
ECM
EIF
NPM
53G
AAQXK
AAYXX
ACNNM
ADMUD
AFFNX
AFJKZ
AGHFR
AGRDE
ASPBG
AVWKF
AZFZN
CITATION
FEDTE
FGOYB
G-2
HEA
HMK
HMO
HMS
HMT
HVGLF
HZ~
R2-
SAE
SCB
SEW
SOC
SPT
WUQ
ZMT
7QO
8FD
FR3
P64
5PM
ID FETCH-LOGICAL-c484t-ae3e60789229b956494473fb2271a546660fc5c6dc0a78ffebd35f1da19e37f93
IEDL.DBID .~1
ISICitedReferencesCount 32
ISICitedReferencesURI https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=CitingArticles&UT=000334337800011
ISSN 0968-0896
IngestDate Tue Sep 17 21:24:14 EDT 2024
Sat Oct 05 06:09:33 EDT 2024
Thu Sep 26 16:01:19 EDT 2024
Sat Nov 02 11:55:40 EDT 2024
Wed Sep 18 09:18:52 EDT 2024
Fri Nov 08 20:01:02 EST 2024
Fri Feb 23 02:30:56 EST 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 7
Keywords Thieno[3,2-d]pyrimidine
Heterocyclic chemistry
Antifungal
Cytostatic
Apoptosis
DESIGN
SERIES
KINASE INHIBITOR
CANCER
DISCOVERY
POTENT
PI3 KINASE
BIOLOGICAL EVALUATION
C-NUCLEOSIDE ISOSTERE
DERIVATIVES
Language English
License Copyright © 2014 Elsevier Ltd. All rights reserved.
LinkModel DirectLink
LogoURL https://exlibris-pub.s3.amazonaws.com/fromwos-v2.jpg
MergedId FETCHMERGED-LOGICAL-c484t-ae3e60789229b956494473fb2271a546660fc5c6dc0a78ffebd35f1da19e37f93
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ORCID 0000-0002-0154-3459
0000-0003-4976-598X
0000-0002-1273-7507
OpenAccessLink https://europepmc.org/articles/pmc4565497?pdf=render
PMID 24631358
PQID 1520390324
PQPubID 23462
PageCount 10
ParticipantIDs webofscience_primary_000334337800011
webofscience_primary_000334337800011CitationCount
pubmed_primary_24631358
pubmedcentral_primary_oai_pubmedcentral_nih_gov_4565497
elsevier_sciencedirect_doi_10_1016_j_bmc_2014_02_033
proquest_miscellaneous_1520390324
crossref_primary_10_1016_j_bmc_2014_02_033
PublicationCentury 2000
PublicationDate 2014-04-01
PublicationDateYYYYMMDD 2014-04-01
PublicationDate_xml – month: 04
  year: 2014
  text: 2014-04-01
  day: 01
PublicationDecade 2010
PublicationPlace OXFORD
PublicationPlace_xml – name: OXFORD
– name: England
PublicationTitle Bioorganic & medicinal chemistry
PublicationTitleAbbrev BIOORGAN MED CHEM
PublicationTitleAlternate Bioorg Med Chem
PublicationYear 2014
Publisher Elsevier Ltd
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: Elsevier
References Fossey, Landelle, Laduree, Robba (b0110) 1994; 13
Munchhof, Beebe, Casavant, Cooper, Doty, Higdon, Hillerman, Soderstrom, Knauth, Marx, Rossi, Sobolov, Sun (b0060) 2004; 14
Sutherlin, Sampath, Berry, Castanedo, Chang, Chuckowree, Dotson, Folkes, Friedman, Goldsmith, Heffron, Lee, Lesnick, Lewis, Mathieu, Nonomiya, Olivero, Pang, Prior, Salphati, Sideris, Tian, Tsui, Wan, Wang, Wiesmann, Wong, Zhu (b0080) 2010; 53
Mathieu, Gradl, Ren, Wen, Aliagas, Gunzner-Toste, Lee, Pulk, Zhao, Alicke, Boggs, Buckmelter, Choo, Dinkel, Gloor, Gould, Hansen, Hastings, Hatzivassiliou, Laird, Moreno, Ran, Voegtli, Wenglowsky, Grina, Rudolph (b0095) 2012; 55
Wallace, Candlish, Hagos, Seley, De Koning (b0135) 2004; 23
Fossey, Laduree, Robba (b0105) 1994; 13
Guimaraes, Kopecky, Mihalic, Shen, Jeffries, Thibault, Chen, Walker, Cardozo (b0180) 2009; 131
Lemke, T. L.; Williams, D. A.; Editors Foye’s Principles of Medicinal Chemistry: Fifth edition, 2002.
Seley, Januszczyk, Hagos, Zhang, Dransfield (b0055) 2000; 43
Shi, Du, Ma, Pankiewicz, Patterson, Tharnish, McBrayer, Stuyver, Otto, Chu, Schinazi, Watanabe (b0160) 2005; 13
Foley, Lazarus, Farber, Uzman, Boone, McCarthy (b0195) 1965; 18
Lim, Klein, Fox (b0010) 1980; 21
Lim, Ren, Otter, Klein (b0025) 1983; 48
Joule, J. A.; Mills, K. Heterocyclic Chemistry: Fourth Edition, 2000.
Cory, Chen, Cory (b0240) 2006; 26
Ren, Rao, Klein (b0030) 1986; 23
Showalter, Bridges, Zhou, Sercel, McMichael, Fry (b0050) 1999; 42
‘Performance Standards for Antimicrobial Susceptibility Testing: 14th Informational Supplement’, National Committee for Clinical Laboratory Standards, 2004.
Eisele, Weller (b0260) 2013; 332
Ren, Lim, Otter, Klein (b0015) 1982; 47
Mollard, Warner, Call, Wade, Bearss, Verma, Sharma, Vankayalapati, Bearss (b0210) 2011; 2
Sutherlin, Bao, Berry, Castanedo, Chuckowree, Dotson, Folks, Friedman, Goldsmith, Gunzner, Heffron, Lesnick, Lewis, Mathieu, Murray, Nonomiya, Pang, Pegg, Prior, Rouge, Salphati, Sampath, Tian, Tsui, Wan, Wang, Wei, Wiesmann, Wu, Zhu, Olivero (b0085) 2011; 54
Pore, Hiltermann, Kruyt (b0265) 2013; 332
Vermes, Haanen, Steffens-Nakken, Reutelingsperger (b0275) 1995; 184
Neidle, Thurston (b0225) 2005; 5
Safina, Baker, Baumgardner, Blaney, Chan, Chen, Cartwright, Castanedo, Chabot, Cheguillaume, Goldsmith, Goldstein, Goyal, Hancox, Handa, Iyer, Kaur, Kondru, Kenny, Krintel, Li, Lesnick, Lucas, Lewis, Mukadam, Murray, Nadin, Nonomiya, Padilla, Palmer, Pang, Pegg, Price, Reif, Salphati, Savy, Seward, Shuttleworth, Sohal, Sweeney, Tay, Tivitmahaisoon, Waszkowycz, Wei, Yue, Zhang, Sutherlin (b0100) 2012; 55
Girgis, Cottam, Larson, Robins (b0185) 1987; 24
Bourke, Burns, Cuzzupe, Feutrill, Kling, Nero (b0150) 2009
Ife, Brown, Blurton, Keeling, Leach, Meeson, Parsons, Theobald (b0040) 1995; 38
Tor, Del Valle, Jaramillo, Srivatsan, Rios, Weizman (b0115) 2007; 63
Temburnikar, Zhang, Seley-Radtke (b0145) 2012; 31
Evans, Furneaux, Hutchison, Kezar, Morris, Schramm, Tyler (b0175) 2001; 66
Kikuchi, Yamamoto, Horoiwa, Hirai, Kasahara, Hariguchi, Matsumoto, Oshima (b0065) 2006; 49
Seley-Radtke, Zhang, Wauchope, Zimmermann, Ivanov, Korba (b0120) 2008; 52
Hayakawa, Kaizawa, Moritomo, Koizumi, Ohishi, Okada, Ohta, Tsukamoto, Parker, Workman, Waterfield (b0070) 2006; 14
Kelly, Lopez-Chavez, Citrin, Janik, Morris (b0255) 2011; 10
Cupps, Wise, Townsend (b0170) 1983; 48
Hanahan, Weinberg Robert (b0250) 2011; 144
Bravo-Altamirano, George, Frantz, LaValle, Tandon, Leimgruber, Sharlow, Lazo, Wang, Wipf (b0155) 2011; 2
Lim, Klein (b0020) 1981; 22
Wade, L. G. Organic Chemistry, 4th Edition, 1998.
Wallin, Edgar, Guan, Berry, Prior, Lee, Lesnick, Lewis, Nonomiya, Pang, Salphati, Olivero, Sutherlin, O’Brien, Spoerke, Patel, Lensun, Kassees, Ross, Lackner, Sampath, Belvin, Friedman (b0090) 2011; 10
Rahbari, R.; Sheahan, T.; Modes, V.; Collier, P.; Macfarlane, C.; Badge, R. M. BioTechniques 2009, 46, 277–278, 280, 282, 284.
Zhang, Wauchope, Seley-Radtke (b0125) 2008; 64
Law, Dunn (b0190) 1949; 10
Temburnikar, Brace, Seley-Radtke (b0140) 2013; 78
Maiuri, Tasdemir, Criollo, Morselli, Vicencio, Carnuccio, Kroemer (b0235) 2009; 16
Scherer, Syverton, Gey (b0200) 1953; 97
Russell, Press, Rampulla, McNally, Falotico, Keiser, Bright, Tobia (b0035) 1988; 31
Wauchope, Tomney, Pepper, Korba, Seley-Radtke (b0130) 2010; 12
Sullivan, Garcia-Welch, White, Lutzker, Hait (b0245) 2002; 2
Richardson, Kaye (b0270) 2008; 1
Crespo, Pages, Vega, Segarra, Lopez, Domenech, Miralpeix, Beleta, Ryder, Palacios (b0045) 1998; 41
Folkes, Ahmadi, Alderton, Alix, Baker, Box, Chuckowree, Clarke, Depledge, Eccles, Friedman, Hayes, Hancox, Kugendradas, Lensun, Moore, Olivero, Pang, Patel, Pergl-Wilson, Raynaud, Robson, Saghir, Salphati, Sohal, Ultsch, Valenti, Wallweber, Wan, Wiesmann, Workman, Zhyvoloup, Zvelebil, Shuttleworth (b0075) 2008; 51
Amarnath, Madhav (b0005) 1974
(b0230) 2002
Kelly, RJ (WOS:000289941600001) 2011; 10
(000334337800011.40) 1000
LIM, MI (WOS:A1983QH60600005) 1983; 48
Seley, KL (WOS:000165866100017) 2000; 43
FOLEY, GE (WOS:A19656307400016) 1965; 18
Sutherlin, DP (WOS:000296408100014) 2011; 54
Rahbari, R (WOS:000266095900005) 2009; 46
LAW, LW (WOS:A1949UF24900018) 1949; 10
Hayakawa, M (WOS:000241227400006) 2006; 14
Joule, J. A. (000334337800011.19) 2000; Fourth
REN, WY (WOS:A1982PR58400005) 1982; 47
(000334337800011.4) 2002
Richardson, Alan (MEDLINE:20021437) 2008; 1
(000334337800011.23) 1000
Neidle, S (WOS:000228091000014) 2005; 5
LIM, MI (WOS:A1981KX03600007) 1981; 22
Folkes, AJ (WOS:000259342700007) 2008; 51
(000334337800011.1) 1000
Pore, MM (WOS:000318378200027) 2013; 332
Mathieu, S (WOS:000301767000029) 2012; 55
Shi, JX (WOS:000227251300024) 2005; 13
Bravo-Altamirano, K (WOS:000287297200012) 2011; 2
Wallace, LJM (WOS:000225113700069) 2004; 23
Wallin, JJ (WOS:000298344400021) 2011; 10
LIM, MI (WOS:A1980JH42000007) 1980; 21
Maiuri, MC (WOS:000261693600011) 2009; 16
CUPPS, TL (WOS:A1983QK09500026) 1983; 48
Mollard, A (WOS:000297947000007) 2011; 2
Temburnikar, K (WOS:000322210700051) 2013; 78
Sutherlin, DP (WOS:000274270900016) 2010; 53
Eisele, G (WOS:000318378200025) 2013; 332
Wauchope, OR (WOS:000282604700009) 2010; 12
Safina, BS (WOS:000305769600018) 2012; 55
FOSSEY, C (WOS:A1994NL49000005) 1994; 13
REN, WY (WOS:A1986F587500031) 1986; 23
Temburnikar, K (WOS:000303579100004) 2012; 31
GIRGIS, NS (WOS:A1987H627300054) 1987; 24
Crespo, MI (WOS:000076374300013) 1998; 41
Kikuchi, H (WOS:000239141500029) 2006; 49
AMARNATH, V (WOS:A1974V163200001) 1974
(000334337800011.51) 1000
FOSSEY, C (WOS:A1994NL49000001) 1994; 13
Sullivan, Gregory F (MEDLINE:12415616); 2
Tor, Y (WOS:000248294800021) 2007; 63
Guimaraes, CRW (WOS:000273615400037) 2009; 131
Zhang, ZB (WOS:000260703200002) 2008; 64
Evans, GB (WOS:000170598900011) 2001; 66
SCHERER, WF (WOS:A1953UD35500008) 1953; 97
Showalter, HDH (WOS:000084640000015) 1999; 42
Cory, AH (WOS:000236674800063) 2006; 26
VERMES, I (WOS:A1995RL33700005) 1995; 184
RUSSELL, RK (WOS:A1988P883100019) 1988; 31
IFE, RJ (WOS:A1995RJ01400027) 1995; 38
Munchhof, MJ (WOS:000187862000001) 2004; 14
Hanahan, D (WOS:000288007100007) 2011; 144
Mollard (10.1016/j.bmc.2014.02.033_b0210) 2011; 2
Shi (10.1016/j.bmc.2014.02.033_b0160) 2005; 13
Ren (10.1016/j.bmc.2014.02.033_b0015) 1982; 47
Zhang (10.1016/j.bmc.2014.02.033_b0125) 2008; 64
Sutherlin (10.1016/j.bmc.2014.02.033_b0080) 2010; 53
Crespo (10.1016/j.bmc.2014.02.033_b0045) 1998; 41
Wallace (10.1016/j.bmc.2014.02.033_b0135) 2004; 23
Scherer (10.1016/j.bmc.2014.02.033_b0200) 1953; 97
Ren (10.1016/j.bmc.2014.02.033_b0030) 1986; 23
(10.1016/j.bmc.2014.02.033_b0230) 2002
Seley-Radtke (10.1016/j.bmc.2014.02.033_b0120) 2008; 52
10.1016/j.bmc.2014.02.033_b0215
Mathieu (10.1016/j.bmc.2014.02.033_b0095) 2012; 55
Amarnath (10.1016/j.bmc.2014.02.033_b0005) 1974
Showalter (10.1016/j.bmc.2014.02.033_b0050) 1999; 42
Guimaraes (10.1016/j.bmc.2014.02.033_b0180) 2009; 131
Fossey (10.1016/j.bmc.2014.02.033_b0110) 1994; 13
Neidle (10.1016/j.bmc.2014.02.033_b0225) 2005; 5
Kelly (10.1016/j.bmc.2014.02.033_b0255) 2011; 10
10.1016/j.bmc.2014.02.033_b0220
Tor (10.1016/j.bmc.2014.02.033_b0115) 2007; 63
Temburnikar (10.1016/j.bmc.2014.02.033_b0140) 2013; 78
Safina (10.1016/j.bmc.2014.02.033_b0100) 2012; 55
Vermes (10.1016/j.bmc.2014.02.033_b0275) 1995; 184
Lim (10.1016/j.bmc.2014.02.033_b0020) 1981; 22
Foley (10.1016/j.bmc.2014.02.033_b0195) 1965; 18
10.1016/j.bmc.2014.02.033_b0205
Law (10.1016/j.bmc.2014.02.033_b0190) 1949; 10
Folkes (10.1016/j.bmc.2014.02.033_b0075) 2008; 51
Seley (10.1016/j.bmc.2014.02.033_b0055) 2000; 43
Maiuri (10.1016/j.bmc.2014.02.033_b0235) 2009; 16
Ife (10.1016/j.bmc.2014.02.033_b0040) 1995; 38
Temburnikar (10.1016/j.bmc.2014.02.033_b0145) 2012; 31
Bravo-Altamirano (10.1016/j.bmc.2014.02.033_b0155) 2011; 2
Wallin (10.1016/j.bmc.2014.02.033_b0090) 2011; 10
Hayakawa (10.1016/j.bmc.2014.02.033_b0070) 2006; 14
Lim (10.1016/j.bmc.2014.02.033_b0025) 1983; 48
Lim (10.1016/j.bmc.2014.02.033_b0010) 1980; 21
Hanahan (10.1016/j.bmc.2014.02.033_b0250) 2011; 144
Richardson (10.1016/j.bmc.2014.02.033_b0270) 2008; 1
Cupps (10.1016/j.bmc.2014.02.033_b0170) 1983; 48
Pore (10.1016/j.bmc.2014.02.033_b0265) 2013; 332
Kikuchi (10.1016/j.bmc.2014.02.033_b0065) 2006; 49
Evans (10.1016/j.bmc.2014.02.033_b0175) 2001; 66
Munchhof (10.1016/j.bmc.2014.02.033_b0060) 2004; 14
Bourke (10.1016/j.bmc.2014.02.033_b0150) 2009
Girgis (10.1016/j.bmc.2014.02.033_b0185) 1987; 24
Sullivan (10.1016/j.bmc.2014.02.033_b0245) 2002; 2
Russell (10.1016/j.bmc.2014.02.033_b0035) 1988; 31
Fossey (10.1016/j.bmc.2014.02.033_b0105) 1994; 13
10.1016/j.bmc.2014.02.033_b0165
Cory (10.1016/j.bmc.2014.02.033_b0240) 2006; 26
Eisele (10.1016/j.bmc.2014.02.033_b0260) 2013; 332
Sutherlin (10.1016/j.bmc.2014.02.033_b0085) 2011; 54
10.1016/j.bmc.2014.02.033_b0280
Wauchope (10.1016/j.bmc.2014.02.033_b0130) 2010; 12
References_xml – volume: 144
  start-page: 646
  year: 2011
  ident: b0250
  publication-title: Cell
  contributor:
    fullname: Weinberg Robert
– volume: 64
  start-page: 10791
  year: 2008
  ident: b0125
  publication-title: Tetrahedron
  contributor:
    fullname: Seley-Radtke
– volume: 24
  start-page: 821
  year: 1987
  ident: b0185
  publication-title: J. Heterocycl. Chem.
  contributor:
    fullname: Robins
– volume: 13
  start-page: 925
  year: 1994
  ident: b0110
  article-title: Nucleosides
  publication-title: Nucleotides Nucleic Acids
  contributor:
    fullname: Robba
– volume: 41
  start-page: 4021
  year: 1998
  ident: b0045
  publication-title: J. Med. Chem.
  contributor:
    fullname: Palacios
– volume: 49
  start-page: 4698
  year: 2006
  ident: b0065
  publication-title: J. Med. Chem.
  contributor:
    fullname: Oshima
– volume: 52
  start-page: 635
  year: 2008
  ident: b0120
  publication-title: Nucleic Acids Symp. Ser.
  contributor:
    fullname: Korba
– year: 2002
  ident: b0230
  publication-title: The Molecular Basis of Human Cancer
– volume: 47
  start-page: 4633
  year: 1982
  ident: b0015
  publication-title: J. Org. Chem.
  contributor:
    fullname: Klein
– volume: 23
  start-page: 1441
  year: 2004
  ident: b0135
  article-title: Nucleosides
  publication-title: Nucleotides Nucleic Acids
  contributor:
    fullname: De Koning
– volume: 184
  start-page: 39
  year: 1995
  ident: b0275
  publication-title: J. Immunol. Methods
  contributor:
    fullname: Reutelingsperger
– volume: 23
  start-page: 1757
  year: 1986
  ident: b0030
  publication-title: J. Heterocycl. Chem.
  contributor:
    fullname: Klein
– volume: 10
  start-page: 2426
  year: 2011
  ident: b0090
  publication-title: Mol. Cancer Ther.
  contributor:
    fullname: Friedman
– volume: 78
  start-page: 7305
  year: 2013
  ident: b0140
  publication-title: J. Org. Chem.
  contributor:
    fullname: Seley-Radtke
– volume: 55
  start-page: 2869
  year: 2012
  ident: b0095
  publication-title: J. Med. Chem.
  contributor:
    fullname: Rudolph
– volume: 13
  start-page: 1641
  year: 2005
  ident: b0160
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Watanabe
– volume: 10
  start-page: 179
  year: 1949
  ident: b0190
  publication-title: J. Natl. Cancer. Inst.
  contributor:
    fullname: Dunn
– volume: 48
  start-page: 1060
  year: 1983
  ident: b0170
  publication-title: J. Org. Chem.
  contributor:
    fullname: Townsend
– volume: 1
  start-page: 244
  year: 2008
  ident: b0270
  publication-title: Curr. Mol. Pharmacol.
  contributor:
    fullname: Kaye
– year: 2009
  ident: b0150
  article-title: Cytopia Research Pty Ltd, Australia
  contributor:
    fullname: Nero
– volume: 63
  start-page: 3608
  year: 2007
  ident: b0115
  publication-title: Tetrahedron
  contributor:
    fullname: Weizman
– volume: 26
  start-page: 1289
  year: 2006
  ident: b0240
  publication-title: Anticancer Res.
  contributor:
    fullname: Cory
– volume: 53
  start-page: 1086
  year: 2010
  ident: b0080
  publication-title: J. Med. Chem.
  contributor:
    fullname: Zhu
– volume: 55
  start-page: 5887
  year: 2012
  ident: b0100
  publication-title: J. Med. Chem.
  contributor:
    fullname: Sutherlin
– volume: 18
  start-page: 522
  year: 1965
  ident: b0195
  publication-title: Cancer
  contributor:
    fullname: McCarthy
– volume: 2
  start-page: 19
  year: 2002
  ident: b0245
  publication-title: J. Exp. Ther. Oncol.
  contributor:
    fullname: Hait
– volume: 2
  start-page: 154
  year: 2011
  ident: b0155
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Wipf
– volume: 97
  start-page: 695
  year: 1953
  ident: b0200
  publication-title: J. Exp. Med.
  contributor:
    fullname: Gey
– volume: 21
  start-page: 1013
  year: 1980
  ident: b0010
  publication-title: Tetrahedron Lett.
  contributor:
    fullname: Fox
– volume: 66
  start-page: 5723
  year: 2001
  ident: b0175
  publication-title: J. Org. Chem.
  contributor:
    fullname: Tyler
– volume: 38
  start-page: 2763
  year: 1995
  ident: b0040
  publication-title: J. Med. Chem.
  contributor:
    fullname: Theobald
– volume: 43
  start-page: 4877
  year: 2000
  ident: b0055
  publication-title: J. Med. Chem.
  contributor:
    fullname: Dransfield
– volume: 14
  start-page: 6847
  year: 2006
  ident: b0070
  publication-title: Bioorg. Med. Chem.
  contributor:
    fullname: Waterfield
– volume: 22
  start-page: 25
  year: 1981
  ident: b0020
  publication-title: Tetrahedron Lett.
  contributor:
    fullname: Klein
– volume: 2
  start-page: 907
  year: 2011
  ident: b0210
  publication-title: ACS Med. Chem. Lett.
  contributor:
    fullname: Bearss
– volume: 5
  start-page: 285
  year: 2005
  ident: b0225
  publication-title: Nat. Rev. Cancer
  contributor:
    fullname: Thurston
– volume: 54
  start-page: 7579
  year: 2011
  ident: b0085
  publication-title: J. Med. Chem.
  contributor:
    fullname: Olivero
– volume: 10
  start-page: 35
  year: 2011
  ident: b0255
  publication-title: Mol. Cancer
  contributor:
    fullname: Morris
– volume: 13
  start-page: 883
  year: 1994
  ident: b0105
  article-title: Nucleosides
  publication-title: Nucleotides Nucleic Acids
  contributor:
    fullname: Robba
– volume: 332
  start-page: 359
  year: 2013
  ident: b0265
  publication-title: Cancer Lett.
  contributor:
    fullname: Kruyt
– volume: 12
  start-page: 4466
  year: 2010
  ident: b0130
  publication-title: Org. Lett.
  contributor:
    fullname: Seley-Radtke
– start-page: 837
  year: 1974
  ident: b0005
  publication-title: Synthesis
  contributor:
    fullname: Madhav
– volume: 31
  start-page: 319
  year: 2012
  ident: b0145
  publication-title: Nucleosides, Nucleotides, Nucleic Acids
  contributor:
    fullname: Seley-Radtke
– volume: 42
  start-page: 5464
  year: 1999
  ident: b0050
  publication-title: J. Med. Chem.
  contributor:
    fullname: Fry
– volume: 131
  start-page: 18139
  year: 2009
  ident: b0180
  publication-title: J. Am. Chem. Soc.
  contributor:
    fullname: Cardozo
– volume: 16
  start-page: 87
  year: 2009
  ident: b0235
  publication-title: Cell Death Differ.
  contributor:
    fullname: Kroemer
– volume: 332
  start-page: 335
  year: 2013
  ident: b0260
  publication-title: Cancer Lett.
  contributor:
    fullname: Weller
– volume: 51
  start-page: 5522
  year: 2008
  ident: b0075
  publication-title: J. Med. Chem.
  contributor:
    fullname: Shuttleworth
– volume: 14
  start-page: 21
  year: 2004
  ident: b0060
  publication-title: Bioorg. Med. Chem. Lett.
  contributor:
    fullname: Sun
– volume: 48
  start-page: 780
  year: 1983
  ident: b0025
  publication-title: J. Org. Chem.
  contributor:
    fullname: Klein
– volume: 31
  start-page: 1786
  year: 1988
  ident: b0035
  publication-title: J. Med. Chem.
  contributor:
    fullname: Tobia
– volume: 66
  start-page: 5723
  year: 2001
  ident: WOS:000170598900011
  article-title: Addition of lithiated 9-deazapurine derivatives to a carbohydrate cyclic imine: Convergent synthesis of the aza-C-nucleoside immucillins
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  doi: 10.1021/jo0155613
  contributor:
    fullname: Evans, GB
– volume: 144
  start-page: 646
  year: 2011
  ident: WOS:000288007100007
  article-title: Hallmarks of Cancer: The Next Generation
  publication-title: CELL
  doi: 10.1016/j.cell.2011.02.013
  contributor:
    fullname: Hanahan, D
– year: 1000
  ident: 000334337800011.40
  publication-title: NUCL ACIDS S SER
– volume: 49
  start-page: 4698
  year: 2006
  ident: WOS:000239141500029
  article-title: Exploration of a new type of antimalarial compounds based on febrifugine
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm0601809
  contributor:
    fullname: Kikuchi, H
– volume: 24
  start-page: 821
  year: 1987
  ident: WOS:A1987H627300054
  article-title: 9-DEAZAPURINE NUCLEOSIDES - THE SYNTHESIS OF CERTAIN N-5-2'-DEOXY-BETA-D-ERYTHROPENTOFURANOSYL AND N-5-BETA-D-ARABINOFURANOSYLPYRROLO[3,2-D]PYRIMIDINES
  publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY
  contributor:
    fullname: GIRGIS, NS
– volume: 64
  start-page: 10791
  year: 2008
  ident: WOS:000260703200002
  article-title: Mechanistic studies in the synthesis of a series of thieno-expanded xanthosine and guanosine nucleosides
  publication-title: TETRAHEDRON
  contributor:
    fullname: Zhang, ZB
– volume: 97
  start-page: 695
  year: 1953
  ident: WOS:A1953UD35500008
  article-title: STUDIES ON THE PROPAGATION INVITRO OF POLIOMYELITIS VIRUSES .4. VIRAL MULTIPLICATION IN A STABLE STRAIN OF HUMAN MALIGNANT EPITHELIAL CELLS (STRAIN HELA) DERIVED FROM AN EPIDERMOID CARCINOMA OF THE CERVIX
  publication-title: JOURNAL OF EXPERIMENTAL MEDICINE
  contributor:
    fullname: SCHERER, WF
– volume: 13
  start-page: 883
  year: 1994
  ident: WOS:A1994NL49000001
  article-title: SYNTHESIS OF ACYCLIC THIENO[3,2-D]PYRIMIDINE NUCLEOSIDES AND AZIDO DERIVATIVES AS POTENTIAL ANTI-HIV AGENTS
  publication-title: NUCLEOSIDES & NUCLEOTIDES
  contributor:
    fullname: FOSSEY, C
– start-page: 837
  year: 1974
  ident: WOS:A1974V163200001
  article-title: SURVEY OF METHODS FOR PREPARATION OF PYRROLOPYRIMIDINES
  publication-title: SYNTHESIS-STUTTGART
  contributor:
    fullname: AMARNATH, V
– volume: 22
  start-page: 25
  year: 1981
  ident: WOS:A1981KX03600007
  article-title: SYNTHESIS OF 9-DEAZAADENOSINE - A NEW CYTO-TOXIC C-NUCLEOSIDE ISOSTERE OF ADENOSINE
  publication-title: TETRAHEDRON LETTERS
  contributor:
    fullname: LIM, MI
– volume: 12
  start-page: 4466
  year: 2010
  ident: WOS:000282604700009
  article-title: Tricyclic 2 '-C-Modified Nucleosides as Potential Anti-HCV Therapeutics
  publication-title: ORGANIC LETTERS
  doi: 10.1021/ol101482h
  contributor:
    fullname: Wauchope, OR
– volume: 54
  start-page: 7579
  year: 2011
  ident: WOS:000296408100014
  article-title: Discovery of a Potent, Selective, and Orally Available Class I Phosphatidylinositol 3-Kinase (PI3K)/Mammalian Target of Rapamycin (mTOR) Kinase Inhibitor (GDC-0980) for the Treatment of Cancer
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm2009327
  contributor:
    fullname: Sutherlin, DP
– volume: 41
  start-page: 4021
  year: 1998
  ident: WOS:000076374300013
  article-title: Design, synthesis, and biological activities of new thieno[3,2-d]pyrimidines as selective type 4 phosphodiesterase inhibitors
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  contributor:
    fullname: Crespo, MI
– volume: 10
  start-page: 2426
  year: 2011
  ident: WOS:000298344400021
  article-title: GDC-0980 Is a Novel Class I PI3K/mTOR Kinase Inhibitor with Robust Activity in Cancer Models Driven by the PI3K Pathway
  publication-title: MOLECULAR CANCER THERAPEUTICS
  doi: 10.1158/1535-7163.MCT-11-0446
  contributor:
    fullname: Wallin, JJ
– volume: 31
  start-page: 1786
  year: 1988
  ident: WOS:A1988P883100019
  article-title: THIOPHENE SYSTEMS .9. THIENOPYRIMIDINEDIONE DERIVATIVES AS POTENTIAL ANTIHYPERTENSIVE AGENTS
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  contributor:
    fullname: RUSSELL, RK
– volume: 16
  start-page: 87
  year: 2009
  ident: WOS:000261693600011
  article-title: Control of autophagy by oncogenes and tumor suppressor genes
  publication-title: CELL DEATH AND DIFFERENTIATION
  doi: 10.1038/cdd.2008.131
  contributor:
    fullname: Maiuri, MC
– volume: 1
  start-page: 244
  year: 2008
  ident: MEDLINE:20021437
  article-title: Pharmacological inhibition of the Bcl-2 family of apoptosis regulators as cancer therapy.
  publication-title: Current molecular pharmacology
  contributor:
    fullname: Richardson, Alan
– volume: 332
  start-page: 335
  year: 2013
  ident: WOS:000318378200025
  article-title: Targeting apoptosis pathways in glioblastoma
  publication-title: CANCER LETTERS
  doi: 10.1016/j.canlet.2010.12.012
  contributor:
    fullname: Eisele, G
– volume: 184
  start-page: 39
  year: 1995
  ident: WOS:A1995RL33700005
  article-title: A NOVEL ASSAY FOR APOPTOSIS - FLOW CYTOMETRIC DETECTION OF PHOSPHATIDYLSERINE EXPRESSION ON EARLY APOPTOTIC CELLS USING FLUORESCEIN-LABELED ANNEXIN-V
  publication-title: JOURNAL OF IMMUNOLOGICAL METHODS
  contributor:
    fullname: VERMES, I
– volume: 53
  start-page: 1086
  year: 2010
  ident: WOS:000274270900016
  article-title: Discovery of (Thienopyrimidin-2-yl)aminopyrimidines as Potent, Selective, and Orally Available Pan-PI3-Kinase and Dual Pan-PI3-Kinase/mTOR Inhibitors for the Treatment of Cancer
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm901284w
  contributor:
    fullname: Sutherlin, DP
– volume: 131
  start-page: 18139
  year: 2009
  ident: WOS:000273615400037
  article-title: Thermodynamic Analysis of mRNA Cap Binding by the Human Initiation Factor eIF4E via Free Energy Perturbations
  publication-title: JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
  doi: 10.1021/ja9064359
  contributor:
    fullname: Guimaraes, CRW
– volume: 10
  start-page: ARTN 35
  year: 2011
  ident: WOS:000289941600001
  article-title: Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
  publication-title: MOLECULAR CANCER
  doi: 10.1186/1476-4598-10-35
  contributor:
    fullname: Kelly, RJ
– volume: 10
  start-page: 179
  year: 1949
  ident: WOS:A1949UF24900018
  article-title: OBSERVATIONS ON THE EFFECT OF A FOLIC-ACID ANTAGONIST ON TRANSPLANTABLE LYMPHOID LEUKEMIAS IN MICE
  publication-title: JOURNAL OF THE NATIONAL CANCER INSTITUTE
  contributor:
    fullname: LAW, LW
– volume: 38
  start-page: 2763
  year: 1995
  ident: WOS:A1995RJ01400027
  article-title: REVERSIBLE INHIBITORS OF THE GASTRIC (H+/K+)-ATPASE .5. SUBSTITUTED 2,4-DIAMINOQUINAZOLINES AND THIENOPYRIMIDINES
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  contributor:
    fullname: IFE, RJ
– year: 1000
  ident: 000334337800011.1
  publication-title: PERF STAND ANT SUSC
– volume: 13
  start-page: 1641
  year: 2005
  ident: WOS:000227251300024
  article-title: Synthesis and anti-viral activity of a series of D- and L-2 '-deoxy-2 '-fluororibonucleosides in the subgenomic HCV replicon system
  publication-title: BIOORGANIC & MEDICINAL CHEMISTRY
  doi: 10.1016/j.bmc.2004.12.011
  contributor:
    fullname: Shi, JX
– volume: 63
  start-page: 3608
  year: 2007
  ident: WOS:000248294800021
  article-title: Designing new isomorphic fluorescent nucleobase analogues: the thieno[3,2-d]pyrimidine core
  publication-title: TETRAHEDRON
  doi: 10.1016/j.tet.2007.01.075
  contributor:
    fullname: Tor, Y
– volume: 78
  start-page: 7305
  year: 2013
  ident: WOS:000322210700051
  article-title: Synthesis of 2 '-Deoxy-9-deaza Nucleosides Using Heck Methodology
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  doi: 10.1021/jo400913k
  contributor:
    fullname: Temburnikar, K
– volume: 31
  start-page: 319
  year: 2012
  ident: WOS:000303579100004
  article-title: MODIFIED SYNTHESIS OF 3 '-OTBDPS-PROTECTED FURANOID GLYCAL
  publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
  doi: 10.1080/15257770.2012.656212
  contributor:
    fullname: Temburnikar, K
– year: 1000
  ident: 000334337800011.51
  publication-title: ORGANIC CHEM
– volume: 23
  start-page: 1757
  year: 1986
  ident: WOS:A1986F587500031
  article-title: CONVENIENT SYNTHESIS OF SUBSTITUTED 3-AMINOTHIOPHENE-2-CARBONITRILES FROM ALPHA-ACETYLENIC NITRILES AND THEIR CONVERSION TO THIENO[3,2-D]PYRIMIDINES
  publication-title: JOURNAL OF HETEROCYCLIC CHEMISTRY
  contributor:
    fullname: REN, WY
– volume: 42
  start-page: 5464
  year: 1999
  ident: WOS:000084640000015
  article-title: Tyrosine kinase inhibitors. 16. 6,5,6-tricyclic benzothieno[3,2-d]pyrimidines and pyrimido[5,4-b]- and -[4,5-b]indoles as potent inhibitors of the epidermal growth factor receptor tyrosine kinase
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  contributor:
    fullname: Showalter, HDH
– volume: Fourth
  year: 2000
  ident: 000334337800011.19
  publication-title: Heterocyclic Chemistry
  contributor:
    fullname: Joule, J. A.
– volume: 5
  start-page: 285
  year: 2005
  ident: WOS:000228091000014
  article-title: Chemical approaches to the discovery and development of cancer therapies
  publication-title: NATURE REVIEWS CANCER
  doi: 10.1038/nrc1587
  contributor:
    fullname: Neidle, S
– year: 2002
  ident: 000334337800011.4
  publication-title: MOL BASIS HUMAN CANC
– volume: 21
  start-page: 1013
  year: 1980
  ident: WOS:A1980JH42000007
  article-title: SYNTHESIS OF THE PYRROLO[3,2-D]PYRIMIDINE C-NUCLEOSIDE ISOSTERE OF INOSINE
  publication-title: TETRAHEDRON LETTERS
  contributor:
    fullname: LIM, MI
– volume: 18
  start-page: 522
  year: 1965
  ident: WOS:A19656307400016
  article-title: CONTINUOUS CULTURE OF HUMAN LYMPHOBLASTS FROM PERIPHERAL BLOOD OF A CHILD WITH ACUTE LEUKEMIA
  publication-title: CANCER
  contributor:
    fullname: FOLEY, GE
– volume: 23
  start-page: 1441
  year: 2004
  ident: WOS:000225113700069
  article-title: Selective transport of a new class of purine antimetabolites by the protozoan parasite Trypanosoma brucei
  publication-title: NUCLEOSIDES NUCLEOTIDES & NUCLEIC ACIDS
  doi: 10.1081/NCN-200027660
  contributor:
    fullname: Wallace, LJM
– volume: 55
  start-page: 5887
  year: 2012
  ident: WOS:000305769600018
  article-title: Discovery of Novel PI3-Kinase delta Specific Inhibitors for the Treatment of Rheumatoid Arthritis: Taming CYP3A4 Time-Dependent Inhibition
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm3003747
  contributor:
    fullname: Safina, BS
– volume: 14
  start-page: 6847
  year: 2006
  ident: WOS:000241227400006
  article-title: Synthesis and biological evaluation of 4-morpholino-2-phenylquinazolines and related derivatives as novel PI3 kinase p110 alpha inhibitors
  publication-title: BIOORGANIC & MEDICINAL CHEMISTRY
  doi: 10.1016/j.bmc.2006.06.046
  contributor:
    fullname: Hayakawa, M
– volume: 26
  start-page: 1289
  year: 2006
  ident: WOS:000236674800063
  article-title: Effects of PRIMA-1 on wild-type L1210 cells expressing mutant p53 and drug-resistant L1210 cells lacking expression of p53: Necrosis vs. apoptosis
  publication-title: ANTICANCER RESEARCH
  contributor:
    fullname: Cory, AH
– volume: 14
  start-page: 21
  year: 2004
  ident: WOS:000187862000001
  article-title: Design and SAR of thienopyrimidine and thienopyridine inhibitors of VEGFR-2 kinase activity
  publication-title: BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
  doi: 10.1016/j.bmcl.2003.10.030
  contributor:
    fullname: Munchhof, MJ
– volume: 2
  start-page: 907
  year: 2011
  ident: WOS:000297947000007
  article-title: Design, Synthesis, and Biological Evaluation of a Series of Novel AXL Kinase Inhibitors
  publication-title: ACS MEDICINAL CHEMISTRY LETTERS
  doi: 10.1021/ml200198x
  contributor:
    fullname: Mollard, A
– volume: 43
  start-page: 4877
  year: 2000
  ident: WOS:000165866100017
  article-title: Synthesis and antitumor activity of thieno-separated tricyclic purines
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm000326i
  contributor:
    fullname: Seley, KL
– volume: 46
  start-page: 277
  year: 2009
  ident: WOS:000266095900005
  article-title: A novel L1 retrotransposon marker for HeLa cell line identification
  publication-title: BIOTECHNIQUES
  doi: 10.2144/000113089
  contributor:
    fullname: Rahbari, R
– volume: 2
  start-page: 19
  ident: MEDLINE:12415616
  article-title: Augmentation of apoptosis by the combination of bleomycin with trifluoperazine in the presence of mutant p53.
  publication-title: Journal of experimental therapeutics & oncology
  contributor:
    fullname: Sullivan, Gregory F
– year: 1000
  ident: 000334337800011.23
  publication-title: FOYES PRINCIPLES MED
– volume: 13
  start-page: 925
  year: 1994
  ident: WOS:A1994NL49000005
  article-title: SYNTHESIS OF N-1-BETA-D-ARABINOFURANOSYL AND N-1-2'-DEOXY-BETA-D-ERYTHRO-PENTOFURANOSYL THIENO[3,2-D]PYRIMIDINE NUCLEOSIDES
  publication-title: NUCLEOSIDES & NUCLEOTIDES
  contributor:
    fullname: FOSSEY, C
– volume: 48
  start-page: 1060
  year: 1983
  ident: WOS:A1983QK09500026
  article-title: SYNTHETIC STRATEGIES TOWARD THE SYNTHESIS OF 2,4-DIMETHOXYPYRROLO[3,2-D]PYRIMIDINE
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  contributor:
    fullname: CUPPS, TL
– volume: 48
  start-page: 780
  year: 1983
  ident: WOS:A1983QH60600005
  article-title: SYNTHESIS OF 9-DEAZAGUANOSINE AND OTHER NEW PYRROLO[3,2-D]PYRIMIDINE C-NUCLEOSIDES
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  contributor:
    fullname: LIM, MI
– volume: 47
  start-page: 4633
  year: 1982
  ident: WOS:A1982PR58400005
  article-title: SYNTHETIC STUDIES OF THE THIENO[3,2-D]PYRIMIDINE C-NUCLEOSIDE ISOSTERE OF INOSINE
  publication-title: JOURNAL OF ORGANIC CHEMISTRY
  contributor:
    fullname: REN, WY
– volume: 2
  start-page: 154
  year: 2011
  ident: WOS:000287297200012
  article-title: Synthesis and Structure-Activity Relationships of Benzothienothiazepinone Inhibitors of Protein Kinase D
  publication-title: ACS MEDICINAL CHEMISTRY LETTERS
  doi: 10.1021/ml100230n
  contributor:
    fullname: Bravo-Altamirano, K
– volume: 55
  start-page: 2869
  year: 2012
  ident: WOS:000301767000029
  article-title: Potent and Selective Aminopyrimidine-Based B-Raf Inhibitors with Favorable Physicochemical and Pharmacokinetic Properties
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm300016v
  contributor:
    fullname: Mathieu, S
– volume: 332
  start-page: 359
  year: 2013
  ident: WOS:000318378200027
  article-title: Targeting apoptosis pathways in lung cancer
  publication-title: CANCER LETTERS
  doi: 10.1016/j.canlet.2010.09.012
  contributor:
    fullname: Pore, MM
– volume: 51
  start-page: 5522
  year: 2008
  ident: WOS:000259342700007
  article-title: The identification of 2-(1H-indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine (GDC-0941) as a potent, selective, orally bioavailable inhibitor of class I PI3 kinase for the treatment of cancer
  publication-title: JOURNAL OF MEDICINAL CHEMISTRY
  doi: 10.1021/jm800295d
  contributor:
    fullname: Folkes, AJ
– volume: 332
  start-page: 359
  year: 2013
  ident: 10.1016/j.bmc.2014.02.033_b0265
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2010.09.012
  contributor:
    fullname: Pore
– volume: 97
  start-page: 695
  year: 1953
  ident: 10.1016/j.bmc.2014.02.033_b0200
  publication-title: J. Exp. Med.
  doi: 10.1084/jem.97.5.695
  contributor:
    fullname: Scherer
– volume: 5
  start-page: 285
  year: 2005
  ident: 10.1016/j.bmc.2014.02.033_b0225
  publication-title: Nat. Rev. Cancer
  doi: 10.1038/nrc1587
  contributor:
    fullname: Neidle
– volume: 24
  start-page: 821
  year: 1987
  ident: 10.1016/j.bmc.2014.02.033_b0185
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.5570240354
  contributor:
    fullname: Girgis
– volume: 2
  start-page: 19
  year: 2002
  ident: 10.1016/j.bmc.2014.02.033_b0245
  publication-title: J. Exp. Ther. Oncol.
  doi: 10.1046/j.1359-4117.2002.01002.x
  contributor:
    fullname: Sullivan
– volume: 48
  start-page: 780
  year: 1983
  ident: 10.1016/j.bmc.2014.02.033_b0025
  publication-title: J. Org. Chem.
  doi: 10.1021/jo00154a005
  contributor:
    fullname: Lim
– volume: 21
  start-page: 1013
  year: 1980
  ident: 10.1016/j.bmc.2014.02.033_b0010
  publication-title: Tetrahedron Lett.
  doi: 10.1016/S0040-4039(00)78826-5
  contributor:
    fullname: Lim
– ident: 10.1016/j.bmc.2014.02.033_b0280
– volume: 23
  start-page: 1757
  year: 1986
  ident: 10.1016/j.bmc.2014.02.033_b0030
  publication-title: J. Heterocycl. Chem.
  doi: 10.1002/jhet.5570230631
  contributor:
    fullname: Ren
– ident: 10.1016/j.bmc.2014.02.033_b0220
– volume: 26
  start-page: 1289
  year: 2006
  ident: 10.1016/j.bmc.2014.02.033_b0240
  publication-title: Anticancer Res.
  contributor:
    fullname: Cory
– volume: 31
  start-page: 319
  year: 2012
  ident: 10.1016/j.bmc.2014.02.033_b0145
  publication-title: Nucleosides, Nucleotides, Nucleic Acids
  doi: 10.1080/15257770.2012.656212
  contributor:
    fullname: Temburnikar
– volume: 22
  start-page: 25
  year: 1981
  ident: 10.1016/j.bmc.2014.02.033_b0020
  publication-title: Tetrahedron Lett.
  doi: 10.1016/0040-4039(81)80031-7
  contributor:
    fullname: Lim
– volume: 42
  start-page: 5464
  year: 1999
  ident: 10.1016/j.bmc.2014.02.033_b0050
  publication-title: J. Med. Chem.
  doi: 10.1021/jm9903949
  contributor:
    fullname: Showalter
– volume: 1
  start-page: 244
  year: 2008
  ident: 10.1016/j.bmc.2014.02.033_b0270
  publication-title: Curr. Mol. Pharmacol.
  doi: 10.2174/1874467210801030244
  contributor:
    fullname: Richardson
– volume: 16
  start-page: 87
  year: 2009
  ident: 10.1016/j.bmc.2014.02.033_b0235
  publication-title: Cell Death Differ.
  doi: 10.1038/cdd.2008.131
  contributor:
    fullname: Maiuri
– volume: 184
  start-page: 39
  year: 1995
  ident: 10.1016/j.bmc.2014.02.033_b0275
  publication-title: J. Immunol. Methods
  doi: 10.1016/0022-1759(95)00072-I
  contributor:
    fullname: Vermes
– volume: 31
  start-page: 1786
  year: 1988
  ident: 10.1016/j.bmc.2014.02.033_b0035
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00117a019
  contributor:
    fullname: Russell
– volume: 63
  start-page: 3608
  year: 2007
  ident: 10.1016/j.bmc.2014.02.033_b0115
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2007.01.075
  contributor:
    fullname: Tor
– volume: 144
  start-page: 646
  year: 2011
  ident: 10.1016/j.bmc.2014.02.033_b0250
  publication-title: Cell
  doi: 10.1016/j.cell.2011.02.013
  contributor:
    fullname: Hanahan
– year: 2009
  ident: 10.1016/j.bmc.2014.02.033_b0150
  contributor:
    fullname: Bourke
– volume: 13
  start-page: 883
  year: 1994
  ident: 10.1016/j.bmc.2014.02.033_b0105
  article-title: Nucleosides
  publication-title: Nucleotides Nucleic Acids
  doi: 10.1080/15257779408011862
  contributor:
    fullname: Fossey
– volume: 14
  start-page: 6847
  year: 2006
  ident: 10.1016/j.bmc.2014.02.033_b0070
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2006.06.046
  contributor:
    fullname: Hayakawa
– volume: 18
  start-page: 522
  year: 1965
  ident: 10.1016/j.bmc.2014.02.033_b0195
  publication-title: Cancer
  doi: 10.1002/1097-0142(196504)18:4<522::AID-CNCR2820180418>3.0.CO;2-J
  contributor:
    fullname: Foley
– volume: 43
  start-page: 4877
  year: 2000
  ident: 10.1016/j.bmc.2014.02.033_b0055
  publication-title: J. Med. Chem.
  doi: 10.1021/jm000326i
  contributor:
    fullname: Seley
– volume: 10
  start-page: 2426
  year: 2011
  ident: 10.1016/j.bmc.2014.02.033_b0090
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-11-0446
  contributor:
    fullname: Wallin
– volume: 48
  start-page: 1060
  year: 1983
  ident: 10.1016/j.bmc.2014.02.033_b0170
  publication-title: J. Org. Chem.
  doi: 10.1021/jo00155a026
  contributor:
    fullname: Cupps
– volume: 55
  start-page: 2869
  year: 2012
  ident: 10.1016/j.bmc.2014.02.033_b0095
  publication-title: J. Med. Chem.
  doi: 10.1021/jm300016v
  contributor:
    fullname: Mathieu
– volume: 10
  start-page: 35
  year: 2011
  ident: 10.1016/j.bmc.2014.02.033_b0255
  publication-title: Mol. Cancer
  doi: 10.1186/1476-4598-10-35
  contributor:
    fullname: Kelly
– volume: 41
  start-page: 4021
  year: 1998
  ident: 10.1016/j.bmc.2014.02.033_b0045
  publication-title: J. Med. Chem.
  doi: 10.1021/jm981012m
  contributor:
    fullname: Crespo
– volume: 78
  start-page: 7305
  year: 2013
  ident: 10.1016/j.bmc.2014.02.033_b0140
  publication-title: J. Org. Chem.
  doi: 10.1021/jo400913k
  contributor:
    fullname: Temburnikar
– volume: 131
  start-page: 18139
  year: 2009
  ident: 10.1016/j.bmc.2014.02.033_b0180
  publication-title: J. Am. Chem. Soc.
  doi: 10.1021/ja9064359
  contributor:
    fullname: Guimaraes
– volume: 47
  start-page: 4633
  year: 1982
  ident: 10.1016/j.bmc.2014.02.033_b0015
  publication-title: J. Org. Chem.
  doi: 10.1021/jo00145a005
  contributor:
    fullname: Ren
– volume: 12
  start-page: 4466
  year: 2010
  ident: 10.1016/j.bmc.2014.02.033_b0130
  publication-title: Org. Lett.
  doi: 10.1021/ol101482h
  contributor:
    fullname: Wauchope
– volume: 332
  start-page: 335
  year: 2013
  ident: 10.1016/j.bmc.2014.02.033_b0260
  publication-title: Cancer Lett.
  doi: 10.1016/j.canlet.2010.12.012
  contributor:
    fullname: Eisele
– volume: 38
  start-page: 2763
  year: 1995
  ident: 10.1016/j.bmc.2014.02.033_b0040
  publication-title: J. Med. Chem.
  doi: 10.1021/jm00014a027
  contributor:
    fullname: Ife
– volume: 53
  start-page: 1086
  year: 2010
  ident: 10.1016/j.bmc.2014.02.033_b0080
  publication-title: J. Med. Chem.
  doi: 10.1021/jm901284w
  contributor:
    fullname: Sutherlin
– volume: 10
  start-page: 179
  year: 1949
  ident: 10.1016/j.bmc.2014.02.033_b0190
  publication-title: J. Natl. Cancer. Inst.
  contributor:
    fullname: Law
– year: 2002
  ident: 10.1016/j.bmc.2014.02.033_b0230
– ident: 10.1016/j.bmc.2014.02.033_b0215
– volume: 55
  start-page: 5887
  year: 2012
  ident: 10.1016/j.bmc.2014.02.033_b0100
  publication-title: J. Med. Chem.
  doi: 10.1021/jm3003747
  contributor:
    fullname: Safina
– volume: 54
  start-page: 7579
  year: 2011
  ident: 10.1016/j.bmc.2014.02.033_b0085
  publication-title: J. Med. Chem.
  doi: 10.1021/jm2009327
  contributor:
    fullname: Sutherlin
– start-page: 837
  year: 1974
  ident: 10.1016/j.bmc.2014.02.033_b0005
  publication-title: Synthesis
  doi: 10.1055/s-1974-23448
  contributor:
    fullname: Amarnath
– volume: 51
  start-page: 5522
  year: 2008
  ident: 10.1016/j.bmc.2014.02.033_b0075
  publication-title: J. Med. Chem.
  doi: 10.1021/jm800295d
  contributor:
    fullname: Folkes
– volume: 66
  start-page: 5723
  year: 2001
  ident: 10.1016/j.bmc.2014.02.033_b0175
  publication-title: J. Org. Chem.
  doi: 10.1021/jo0155613
  contributor:
    fullname: Evans
– ident: 10.1016/j.bmc.2014.02.033_b0205
  doi: 10.2144/000113089
– volume: 64
  start-page: 10791
  year: 2008
  ident: 10.1016/j.bmc.2014.02.033_b0125
  publication-title: Tetrahedron
  doi: 10.1016/j.tet.2008.09.011
  contributor:
    fullname: Zhang
– volume: 2
  start-page: 907
  year: 2011
  ident: 10.1016/j.bmc.2014.02.033_b0210
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/ml200198x
  contributor:
    fullname: Mollard
– volume: 2
  start-page: 154
  year: 2011
  ident: 10.1016/j.bmc.2014.02.033_b0155
  publication-title: ACS Med. Chem. Lett.
  doi: 10.1021/ml100230n
  contributor:
    fullname: Bravo-Altamirano
– ident: 10.1016/j.bmc.2014.02.033_b0165
– volume: 14
  start-page: 21
  year: 2004
  ident: 10.1016/j.bmc.2014.02.033_b0060
  publication-title: Bioorg. Med. Chem. Lett.
  doi: 10.1016/j.bmcl.2003.10.030
  contributor:
    fullname: Munchhof
– volume: 52
  start-page: 635
  year: 2008
  ident: 10.1016/j.bmc.2014.02.033_b0120
  publication-title: Nucleic Acids Symp. Ser.
  doi: 10.1093/nass/nrn321
  contributor:
    fullname: Seley-Radtke
– volume: 13
  start-page: 925
  year: 1994
  ident: 10.1016/j.bmc.2014.02.033_b0110
  article-title: Nucleosides
  publication-title: Nucleotides Nucleic Acids
  doi: 10.1080/15257779408011866
  contributor:
    fullname: Fossey
– volume: 49
  start-page: 4698
  year: 2006
  ident: 10.1016/j.bmc.2014.02.033_b0065
  publication-title: J. Med. Chem.
  doi: 10.1021/jm0601809
  contributor:
    fullname: Kikuchi
– volume: 23
  start-page: 1441
  year: 2004
  ident: 10.1016/j.bmc.2014.02.033_b0135
  article-title: Nucleosides
  publication-title: Nucleotides Nucleic Acids
  doi: 10.1081/NCN-200027660
  contributor:
    fullname: Wallace
– volume: 13
  start-page: 1641
  year: 2005
  ident: 10.1016/j.bmc.2014.02.033_b0160
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2004.12.011
  contributor:
    fullname: Shi
SSID ssj0002491
Score 2.3079338
Snippet The in vitro evaluation of thieno[3,2-d]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer...
The in vitro evaluation of thieno[3,2- d ]pyrimidines identified halogenated compounds 1 and 2 with antiproliferative activity against three different cancer...
Source Web of Science
SourceID pubmedcentral
proquest
crossref
pubmed
webofscience
elsevier
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 2113
SubjectTerms Anti-Bacterial Agents - chemical synthesis
Anti-Bacterial Agents - chemistry
Anti-Bacterial Agents - pharmacology
Antifungal
Antifungal Agents - chemical synthesis
Antifungal Agents - chemistry
Antifungal Agents - pharmacology
Antineoplastic Agents - chemical synthesis
Antineoplastic Agents - chemistry
Antineoplastic Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Bacillus subtilis - drug effects
Biochemistry & Molecular Biology
Cell Cycle - drug effects
Cell Proliferation - drug effects
Chemistry
Chemistry, Medicinal
Chemistry, Organic
Cytostatic
Dose-Response Relationship, Drug
Drug Screening Assays, Antitumor
Fungi - drug effects
Heterocyclic chemistry
Humans
Life Sciences & Biomedicine
Microbial Sensitivity Tests
Molecular Structure
Pharmacology & Pharmacy
Physical Sciences
Pyrimidines - chemical synthesis
Pyrimidines - chemistry
Pyrimidines - pharmacology
Science & Technology
Structure-Activity Relationship
Thieno[3,2-d]pyrimidine
Tumor Cells, Cultured
Title Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines
URI https://dx.doi.org/10.1016/j.bmc.2014.02.033
http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestApp=WOS&DestLinkType=FullRecord&UT=000334337800011
https://www.ncbi.nlm.nih.gov/pubmed/24631358
https://search.proquest.com/docview/1520390324
https://pubmed.ncbi.nlm.nih.gov/PMC4565497
Volume 22
WOS 000334337800011
WOSCitedRecordID wos000334337800011
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB5VrQRcEGx5pEAVpIoDImxiO3F8XC1UC6i9QKVKCFlObGsXqdkVTSv10t_eGSdZWF5CHJPYkTVjz3xjj78BOFCZFdwpmWSssAkaPJMYWauEFxgP1TlT3tNt5KPjYnYi3p_mp1swHe7CUFplb_s7mx6sdf9m3EtzvFosxh8RfJdpqdC_BBxDnKAC3R_O6dfX39M8MLwIVfOwcUKth5PNkONVnRGLYSYCbSfnf_JNv2LP36dQ_uS2gos6vAd3e2wZT7rh34ct14xgd9JgXH12Fb-IQ7Zn2EYfwe3pUOltBLeO-gP2XXgzadrFiir5eNdxgsd08-Ey8K7GSx_PabPH4S-djds5DmP5mb9iif2yuqICYZay6B_AyeHbT9NZ0hdaSGpRijYxjruCeOcZUxUGTEIJIbmvGJOZyQVGOKmv87qwdWpk6b2rLM99Zk2mHJde8Yew3Swb9xhiKVxdIYqQtE9ifFpVBteh9cIbz9OKRfByELFedXwaekg0-6pRH5r0oVOmUR8RiEEJemNSaLT3f-v2fFCYRknSCYhp3PLiXCNYSblKEURG8KhT4HoUTBQ843kZgdxQ7boBEXFvfmkW80DITahYKBnBwY-TYN2R4k4uOJdlQOARZP_SbNpztBM3Qbv3f5J4Anfoqcs0egrb7bcL9wxBVFvth1WyDzuTdx9mxzcn2hqf
link.rule.ids 230,315,783,787,888,4509,24128,27936,27937,45597,45691
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwED6NITFeEHT8CDAI0sQDImtiO3H8WHVMBda9sEmTELKcxFaLtLTaMqS98Ldz5yQdZYAQr7EdWXf23Xf2-TuAXZVUglslo4RlVYQGz0RGliriGcZDZcqUc_QaeXqUTU7Eh9P0dAPG_VsYSqvsbH9r07217r4MO2kOl_P58BOC7zzOFfoXj2PELbgtCB_jot77fp3ngfGFL5uHvSPq3l9t-iSv4oxoDBPheTs5_5Nzugk-f59D-Yvf8j7q4D7c68BlOGrn_wA2bD2A7VGNgfXZVfg69Ome_hx9AFvjvtTbAO5Muxv2bdgf1c18SaV8nG1JwUN6-vDNE6-GCxfO6LTH4i9tFTYznMbiM3_LourL8ooqhFWURv8QTg7eHY8nUVdpISpFLprIWG4zIp5nTBUYMQklhOSuYEwmJhUY4sSuTMusKmMjc-dsUfHUJZVJlOXSKf4INutFbZ9AKIUtC4QRkg5KjIuLwuBGrJxwxvG4YAG86UWsly2hhu4zzb5q1IcmfeiYadRHAKJXgl5bFRoN_t-GveoVplGSdAViaru4vNCIVmKuYkSRATxuFbiaBRMZT3iaByDXVLvqQEzc6y31fOYZuQkWCyUD2P15EawGUuDJBecy9xA8gORfuo07knYiJ2ie_p8kXsLW5Hh6qA_fH318BneppU07eg6bzfml3UFE1RQv_I75AZBKHDg
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Antiproliferative+activities+of+halogenated+thieno%5B3%2C2-d%5Dpyrimidines&rft.jtitle=Bioorganic+%26+medicinal+chemistry&rft.au=Temburnikar%2C+Kartik+W&rft.au=Zimmermann%2C+Sarah+C&rft.au=Kim%2C+Nathaniel+T&rft.au=Ross%2C+Christina+R&rft.date=2014-04-01&rft.issn=0968-0896&rft.volume=22&rft.issue=7&rft.spage=2113&rft.epage=2122&rft_id=info:doi/10.1016%2Fj.bmc.2014.02.033&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0968-0896&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0968-0896&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0968-0896&client=summon